A survey of eMedia-delivered interventions for schizophrenia used in randomized controlled trials.
Farooq Naeem, Tariq Munshi, Shuo Xiang, Megan Yang, Farhad Shokraneh, Yumeen Syed, Muhammad Ayub, Clive E Adams, Saeed Farooq
Author Information
Farooq Naeem: Department of Psychiatry, Queens University, Kingston, ON, Canada.
Tariq Munshi: Department of Psychiatry, Queens University, Kingston, ON, Canada.
Shuo Xiang: Department of Psychiatry, Queens University, Kingston, ON, Canada.
Megan Yang: Department of Psychiatry, Queens University, Kingston, ON, Canada.
Farhad Shokraneh: Institute of Mental Health, Nottingham, UK.
Yumeen Syed: Trenlogic, Toronto, ON, Canada.
Muhammad Ayub: Department of Psychiatry, Queens University, Kingston, ON, Canada.
Clive E Adams: Nottingham University, Nottingham.
Saeed Farooq: Keele University, Stafford, UK.
中文译文
English
BACKGROUND: Randomized trials evaluating electronic Media (eMedia) delivery of interventions are increasingly frequent in mental health. Although a number of reviews have reported efficacy of these interventions, none has reviewed the type of eMedia interventions and quality of their description. We therefore decided to conduct a survey of eMedia-delivered interventions for schizophrenia. METHODS: We surveyed all relevant trials reliably identified in the Cochrane Schizophrenia Group's comprehensive register of trials by authors working independently. Data were extracted regarding the size of the trial, interventions, outcomes and how well the intervention was described. RESULTS: eMedia delivery of interventions is increasingly frequent in trials relevant to the care of people with schizophrenia. The trials varied considerably in sample sizes (mean =123, median =87, range =20-507), and interventions were diverse, rarely evaluating the same approaches and were poorly reported. This makes replication impossible. Outcomes in these studies are limited, have not been noted to be chosen by end users and seem unlikely to be easy to apply in routine care. No study reported on potential adverse effects or cost, end users satisfaction or ease of use. None of the papers mentioned the use of CONSORT eHealth guidelines. CONCLUSION: There is a need to improve reporting and testing of psychosocial interventions delivered by eMedia. New trials should comply with CONSORT eHealth guidance on design, conduct and reporting, and existing CONSORT should be updated regularly, as the field is constantly evolving.
J Clin Psychiatry. 2012 Jul;73(7):1016-22
[PMID: 22687548 ]
Psychiatry Res. 2011 Sep 30;189(2):166-72
[PMID: 21529970 ]
BMC Psychiatry. 2012 Oct 17;12:172
[PMID: 23075387 ]
Psychiatry Res. 2015 Jan 30;225(1-2):93-8
[PMID: 25467705 ]
Aust N Z J Psychiatry. 2009 Sep;43(9):787-94
[PMID: 19670051 ]
Psychiatr Serv. 2002 May;53(5):545-7
[PMID: 11986501 ]
Psychol Med. 2011 Jan;41(1):163-73
[PMID: 20380784 ]
Behav Cogn Psychother. 2014 Jul;42(4):421-34
[PMID: 23631951 ]
Am J Psychiatry. 2007 Mar;164(3):437-41
[PMID: 17329468 ]
J Clin Epidemiol. 2009 May;62(5):464-75
[PMID: 19348971 ]
Psychiatry Res. 2009 Oct 30;169(3):191-6
[PMID: 19740550 ]
Schizophr Res. 2009 Jun;111(1-3):153-8
[PMID: 19395240 ]
Front Pharmacol. 2013 Aug 09;4:100
[PMID: 23950746 ]
J Med Internet Res. 2010 Dec 19;12(5):e62
[PMID: 21169175 ]
Br J Psychiatry. 2013 Jun;202:428-33
[PMID: 23429202 ]
Neuropsychol Rehabil. 2010 Oct;20(5):659-74
[PMID: 20661811 ]
Arch Psychiatr Nurs. 2014 Jun;28(3):197-9
[PMID: 24856273 ]
Psychiatr Serv. 2011 Jan;62(1):54-60
[PMID: 21209300 ]
J Med Internet Res. 2013 Oct 07;15(10):e216
[PMID: 24100091 ]
Schizophr Res. 2015 Aug;166(1-3):86-91
[PMID: 26032567 ]
Schizophr Bull. 2013 Sep;39(5):999-1007
[PMID: 23086987 ]
Qual Life Res. 2012 Mar;21(2):247-56
[PMID: 21655934 ]
J Med Internet Res. 2014 Sep 15;16(9):e210
[PMID: 25223398 ]
Schizophr Res. 2013 Oct;150(1):240-4
[PMID: 23998952 ]
Neuropsychiatr. 2011;25(2):85-92
[PMID: 21672507 ]
Schizophr Res. 2011 Dec;133(1-3):223-31
[PMID: 21907544 ]
Issues Ment Health Nurs. 2014 May;35(5):323-9
[PMID: 24766166 ]
Br J Psychiatry. 2015 Apr;206(4):263-5
[PMID: 25833865 ]
J Psychiatr Res. 2015 Sep;68:8-18
[PMID: 26228394 ]
Ann Intern Med. 2008 Feb 19;148(4):295-309
[PMID: 18283207 ]
Psychiatr Rehabil J. 2014 Sep;37(3):222-31
[PMID: 24978623 ]
BMJ. 2013 Sep 26;347:f5841
[PMID: 24072875 ]
Cochrane Database Syst Rev. 2013 Sep 09;(9):CD005330
[PMID: 24018460 ]
BMJ. 2001 Apr 7;322(7290):835-40
[PMID: 11290639 ]
Schizophr Res. 2012 Aug;139(1-3):92-8
[PMID: 22682988 ]
Psychiatr Serv. 2002 Jul;53(7):799-801
[PMID: 12096159 ]
J Med Internet Res. 2013 Apr 24;15(4):e89
[PMID: 23615332 ]
Asia Pac Psychiatry. 2013 Jun;5(2):90-100
[PMID: 23857809 ]
BMC Med. 2010 Mar 24;8:18
[PMID: 20334633 ]
Schizophr Res. 2011 Feb;125(2-3):284-90
[PMID: 21094025 ]
Schizophr Bull. 2005 Oct;31(4):898-909
[PMID: 16079391 ]
Psychiatry Res. 2016 May 30;239:111-6
[PMID: 27137970 ]
J Psychiatr Res. 2011 Aug;45(8):1113-22
[PMID: 21377168 ]
Rehabil Psychol. 2005 Nov;50(4):325-336
[PMID: 26321774 ]
Am J Psychiatry. 2009 Jul;166(7):805-11
[PMID: 19448187 ]
Br J Psychiatry. 2007 Nov;191:420-6
[PMID: 17978322 ]
World J Psychiatry. 2016 Jun 22;6(2):187-91
[PMID: 27354959 ]
Psychiatr Serv. 2008 Jul;59(7):776-81
[PMID: 18586995 ]
J Nerv Ment Dis. 2003 Feb;191(2):87-92
[PMID: 12586961 ]
Schizophr Res. 2013 Nov;150(2-3):563-9
[PMID: 24035402 ]
Arch Gen Psychiatry. 2001 Aug;58(8):763-8
[PMID: 11483142 ]
Eur Arch Psychiatry Clin Neurosci. 1991;240(4-5):282-7
[PMID: 1829004 ]
Stud Health Technol Inform. 2014;205:843-7
[PMID: 25160306 ]
J Med Internet Res. 2011 Dec 31;13(4):e126
[PMID: 22209829 ]
Schizophr Res. 2013 Oct;150(1):69-75
[PMID: 23962828 ]
Psychol Med. 2014 Jul;44(9):1889-99
[PMID: 24172842 ]
Stud Health Technol Inform. 2013;192:657-61
[PMID: 23920638 ]
Am J Psychiatry. 2005 Jan;162(1):186-8
[PMID: 15625221 ]
Soc Sci Med. 2011 Jan;72(1):54-62
[PMID: 21112682 ]
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002206
[PMID: 16437442 ]
Telemed J E Health. 2005 Dec;11(6):675-83
[PMID: 16430387 ]
Acta Neuropsychiatr. 2006 Dec;18(6):253
[PMID: 27397191 ]
Schizophr Res. 2012 Aug;139(1-3):53-9
[PMID: 22695257 ]
Int J Clin Pract. 2008 Dec;62(12):1943-6
[PMID: 18795967 ]
Am J Psychiatry. 1983 Mar;140(3):345-7
[PMID: 6829808 ]
Psychiatr Serv. 2011 Nov;62(11):1296-302
[PMID: 22211208 ]
Cochrane Database Syst Rev. 2013 Jul 23;(7):CD009453
[PMID: 23881731 ]
Am J Psychiatry. 2010 Feb;167(2):170-80
[PMID: 20008941 ]
Schizophr Res. 2013 Mar;144(1-3):51-62
[PMID: 23356951 ]
Cochrane Database Syst Rev. 2012 Oct 17;10:CD007198
[PMID: 23076932 ]
JMIR Mhealth Uhealth. 2015 Jun 03;3(2):e64
[PMID: 26041730 ]
Trials. 2011 Feb 09;12:35
[PMID: 21306612 ]
J Clin Psychiatry. 2004 Oct;65(10):1343-51
[PMID: 15491237 ]
Schizophr Res. 2015 Oct;168(1-2):514-22
[PMID: 26293215 ]